Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes

Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes

ABSTRACT Objective: There is controversy about the indication for nonalcoholic fatty liver disease (NAFLD) screening in patients with type 2 diabetes mellitus (T2D). The present study aims to contribute to NAFLD surveillance in patients with T2D, assessing the association of clinical and biological...

Full description

Bibliographic Details
Main Authors:	Roselee Pozzan, Ronaldo Gama Pena, Cátia Cristina Silva Sousa Vergara Palma, Raquel de Carvalho Abi-Abib, Carlos Terra, Roberta Arnoldi Cobas
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism 2022-06-01
Series:	Archives of Endocrinology and Metabolism
Subjects:	Type 2 diabetes mellitus nonalcoholic fatty liver disease controlled attenuation parameter (CAP) elastography
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022005007206&tlng=en

Similar Items

Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography
by: Adele Taibbi, et al.
Published: (2021-07-01)

A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
by: Hira Hanif, et al.
Published: (2020-10-01)

Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease
by: Seyed Saeed Seyedian, et al.
Published: (2017-01-01)

Elastography—A Bona Fide Non-Invasive Method for Assessing Non-Alcoholic Fatty Liver Disease in Children
by: Cristina Oana Mărginean, et al.
Published: (2021-04-01)

Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
by: Somaya Albhaisi
Published: (2019-09-01)

Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
by: Somaya Albhaisi
Published: (2019-05-01)

Real-Time Shear Wave Elastography for Determining the Ideal Site of Liver Biopsy in Diffuse Liver Disease
by: Yashwant Patidar, et al.
Published: (2024-01-01)

Nonalcoholic fatty liver disease and Type 2 diabetes mellitus
by: Mala Dharmalingam, et al.
Published: (2018-01-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

Liver Stiffness According to Data of Shear Wave Elastography in Patients with Diabetes Mellitus Type 2 and Nonalcoholic Fatty Liver Disease Depending on Activity of NAFLD
by: O.B. Dynnyk, et al.
Published: (2014-09-01)

Quantitative Assessment of Portal Hypertension by Two-Dimensional Shear Wave Elastography in Rat Models of Nonalcoholic Fatty Liver Disease: Comparison With Four Composite Scores
by: Bingtian Dong, et al.
Published: (2022-03-01)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
by: Yasushi Honda, et al.
Published: (2017-08-01)

Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?
by: Na Di, et al.
Published: (2019-03-01)

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients
by: Ivana Mikolasevic, et al.
Published: (2014-09-01)

Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
by: Stephan Baumeler, et al.
Published: (2019-04-01)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
by: Ozlem Kara, et al.
Published: (2023-09-01)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01)

Non-invasive diagnosis of non-alcoholic fatty liver disease in children: role of shear-wave elastography and steatometry
by: Yu.M. Stepanov, et al.
Published: (2020-10-01)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Yasushi Honda, et al.
Published: (2020-06-01)

Association of nonalcoholic fatty liver disease and liver fibrosis detected by transient elastography with serum retinol in American adults
by: Xiaoxian Niu, et al.
Published: (2023-03-01)

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis
by: Jong Ho Chung, et al.
Published: (2013-06-01)

A Healthful Plant-Based Diet Is Associated with Lower Odds of Nonalcoholic Fatty Liver Disease
by: Xiude Li, et al.
Published: (2022-10-01)

Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

Noninvasive monitoring of liver fat during treatment with GLP‐1 analogues and SGLT‐2 inhibitors in a real‐world setting
by: Vasiliki Mittag‐Roussou, et al.
Published: (2020-07-01)

Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
by: Philippe Garteiser, et al.
Published: (2021-12-01)

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography
by: Kanittha Ratchatasettakul, et al.
Published: (2017-04-01)

The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes
by: Branimir Gjurašin, et al.
Published: (2022-12-01)

Intestinal Elastography in the Diagnostics of Ulcerative Colitis: A Narrative Review
by: Maciej Cebula, et al.
Published: (2022-08-01)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Noninvasive Prediction of Advanced Fibrosis in Pediatric Liver Disease—Discriminatory Performance of 2D Shear Wave Elastography, Transient Elastography and Magnetic Resonance Elastography in Comparison to Histopathology
by: Jon Nielsen, et al.
Published: (2022-11-01)

What is to be done when transient elastography is not feasible?
by: Raluca Lupusoru, et al.
Published: (2016-12-01)

Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
by: Serra JT, et al.
Published: (2020-03-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
by: I G Bakulin, et al.
Published: (2017-02-01)

Combination Therapies for Nonalcoholic Fatty Liver Disease
by: Evangelia S. Makri, et al.
Published: (2022-07-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2023-10-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases
by: Winda P. Bastian, et al.
Published: (2019-03-01)